-- 週三,原油價格上漲,此前有報導稱霍爾木茲海峽發生多起貨櫃船遭槍擊事件,加劇了人們對衝突影響全球供應的擔憂。 布蘭特原油價格上漲0.7%,至每桶99.17美元;西德州中質原油價格上漲0.7%,至每桶90.25美元。路透社週三引述海事安全消息人士和英國海事貿易行動部門的消息報道稱,霍爾木茲海峽至少有三艘貨櫃船遭到槍擊。 報導稱,為使結束戰爭的談判得以繼續進行,美國和伊朗之間的停火協議在到期前數小時被無限期延長。 同時,據報道,烏克蘭總統澤倫斯基表示,從俄羅斯輸送石油的「友誼」輸油管已準備好恢復運作。然而,業內人士在報告中表示,俄羅斯計劃從 5 月 1 日起停止通過該管道從哈薩克向德國出口貨物。
Related Articles
National Australia Bank Shares Down After Resolution of Union Court Proceedings
National Australia Bank (ASX:NAB) shares were down about 1% in recent Monday trade following a Friday settlement with the Finance Sector Union of Australia to resolve court proceedings related to excessive additional working hours for employees.The settlement, reached on a without-admissions basis through mediation, includes the establishment of a health, safety, and well-being framework to mitigate the risks linked to working additional hours, and calls for greater oversight of such risks.The union and the bank said in a joint statement that they are "committed to continuing to work together to ensure fair and sustainable outcomes for all [National Australia Bank] employees."
Clinuvel Pharmaceuticals Says FDA Removes Post-Authorization Requirement for Implant
Clinuvel Pharmaceuticals (ASX:CUV) said the US Food and Drug Administration (FDA) removed a requirement for a post-authorization phase one study on cardiac repolarization in relation to its Scenesse implant upon reviewing its long-term safety profile, according to a Monday filing with the Australian bourse.Scenesse is used to treat patients with erythropoietic protoporphyria, a disease that causes intolerance to light.The FDA concluded that the study was no longer needed since it would not yield valuable safety information, the filing said.
XRF Scientific Completes Acquisition of Combustion Gas Analysis Business
XRF Scientific (ASX:XRF) has completed the acquisition of the combustion gas analysis business from Bruker AXS, according to a Monday Australian bourse filing.The company entered a binding agreement to acquire the combustion gas analysis business for $4 million upfront plus a potential $1 million earnout based on 7% of net revenue over three years, an earlier filing showed.